Dipivefrine
From Wikipedia, the free encyclopedia
| Image:Dipivefrine.png | |
| Dipivefrine
| |
| Systematic (IUPAC) name | |
| [2-(2,2-dimethylpropanoyloxy)-4- (1-hydroxy-2-methylamino-ethyl)- phenyl] 2,2-dimethylpropanoate | |
| Identifiers | |
| CAS number | 52365-63-6 |
| ATC code | S01EA02 |
| PubChem | 3105 |
| DrugBank | APRD00930 |
| Chemical data | |
| Formula | C19H29NO5 |
| Mol. weight | 351.437 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Dipivefrine (Dipivefrin in the United States) is a medicinal drug which is used to treat glaucoma. It is available as ophthalmic solution (eye drops).
| Antiglaucoma preparations and miotics (S01E) edit | ||
|---|---|---|
| Sympathomimetics: |
Apraclonidine, Brimonidine, Clonidine, Dipivefrine, Epinephrine | |
| Parasympathomimetics: |
Aceclidine, Acetylcholine, Carbachol, Demecarium, Echothiophate, Fluostigmine, Neostigmine, Paraoxon, Physostigmine, Pilocarpine | |
| Carbonic anhydrase inhibitors: |
Acetazolamide, Brinzolamide, Diclofenamide, Dorzolamide, Methazolamide | |
| Beta blocking agents: |
Befunolol, Betaxolol, Carteolol, Levobunolol, Metipranolol, Timolol | |
| Prostaglandin analogues: | ||
| Other agents: | ||

